Skip to main content
. 2019 Nov 20;16(23):4589. doi: 10.3390/ijerph16234589

Figure 3.

Figure 3

Kaplan–Meier analysis of survival in patients with endometrial carcinoma (EC) based on pyruvate kinase M2 (PKM2) protein immunostaining. Patients with a higher PKM2 score had a poor overall survival compared with those with a lower score in all patients with EC (p = 0.006).